Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,16132,750,1.15 [0.96-1.38],0.1204148066559905
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,15555,232,1.41 [1.06-1.87],0.0193350995881453
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18193,151,1.29 [0.91-1.82],0.15480144731883
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,11346,848,1.21 [1.02-1.44],0.0280300242216118
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18153,111,1.16 [0.74-1.83],0.5193025759470289
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,16224,72,1.23 [0.70-2.15],0.4743707978348198
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19351,110,1.11 [0.69-1.79],0.6594671379240495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19335,75,0.47 [0.19-1.16],0.1011964225015061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,15816,56,1.43 [0.84-2.42],0.1854951495281644
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18450,104,1.25 [0.79-1.95],0.3396587777533089
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18412,66,1.25 [0.71-2.20],0.4436957272687338
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19419,61,1.00 [0.51-1.96],0.991031949469463
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19465,52,1.21 [0.64-2.29],0.5521891679170228
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19464,51,1.22 [0.65-2.31],0.53309129419885
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,19068,49,1.04 [0.50-2.19],0.910318770813368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18164,356,1.18 [0.92-1.53],0.1968593187295644
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,17926,118,1.27 [0.84-1.91],0.2508437129091336
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18065,257,1.24 [0.94-1.65],0.1342118158470632
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",14031,81,1.10 [0.63-1.90],0.74407188017097
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",13997,47,1.02 [0.48-2.16],0.9578071512752931
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",14282,332,0.86 [0.62-1.19],0.351816053122598
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",14290,340,0.87 [0.63-1.20],0.4094331543687757
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",8065,314,0.98 [0.72-1.33],0.8743348341201101
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6368,169,0.95 [0.60-1.49],0.8232123322425565
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",13998,48,0.73 [0.28-1.88],0.5119508051154902
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,16695,609,1.23 [1.02-1.48],0.0315030777637255
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18152,387,1.08 [0.84-1.39],0.5546776568690301
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,18982,133,1.07 [0.69-1.66],0.750533795741344
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19496,122,1.34 [0.93-1.93],0.11410142097696
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,19225,76,1.05 [0.58-1.87],0.87795075543598
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19501,78,1.29 [0.80-2.07],0.2938785044802433
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Stomach,19548,55,1.53 [0.97-2.39],0.065675781697497
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,19350,244,1.27 [0.96-1.67],0.0938891097953086
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19531,87,1.36 [0.90-2.06],0.1490682792985716
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19536,72,1.11 [0.62-1.98],0.7306088051850719
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19465,49,1.04 [0.50-2.17],0.9087127247531932
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",19468,48,1.08 [0.53-2.21],0.8255364097018967
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,19411,125,1.14 [0.75-1.72],0.5461929986780365
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19531,56,1.11 [0.58-2.10],0.7582433554583172
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,19426,140,0.92 [0.57-1.48],0.7251884409823854
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of breast,10276,36,0.67 [0.22-2.09],0.4935371040600652
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Leiomyoma of uterus,10152,258,1.03 [0.75-1.41],0.8598910008153748
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18273,161,1.27 [0.90-1.79],0.1685356895924116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,17845,270,1.24 [0.95-1.64],0.119241088237051
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,17845,270,1.24 [0.95-1.64],0.119241088237051
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),15761,443,1.35 [1.09-1.67],0.0063531139116677
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19042,49,0.34 [0.11-1.10],0.0720172063518694
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19261,48,1.26 [0.67-2.36],0.4806208875886598
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,14213,1298,1.08 [0.92-1.26],0.3520994153660526
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18120,534,1.34 [1.12-1.62],0.0016104397936166
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17196,110,1.41 [0.95-2.09],0.0887743299858389
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18212,140,1.27 [0.86-1.87],0.2309640674202908
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17188,102,1.48 [1.00-2.18],0.047343231040019
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17715,629,1.11 [0.89-1.39],0.344823720713138
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17696,610,1.11 [0.88-1.39],0.3827042894117205
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,18023,148,1.36 [0.86-2.13],0.1846943161404405
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",18022,147,1.36 [0.86-2.13],0.1849739955821662
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,14061,1146,1.02 [0.86-1.21],0.847103366801937
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13061,146,0.99 [0.62-1.58],0.9608254505646237
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,13977,1062,1.03 [0.86-1.23],0.738559048710385
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,12961,46,1.69 [1.07-2.66],0.023765621366226
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",12986,71,1.63 [1.12-2.38],0.0114226292336399
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,16090,435,1.15 [0.90-1.46],0.263305830702473
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",15792,137,1.05 [0.64-1.71],0.8540713074940055
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19237,94,0.98 [0.54-1.79],0.9589382552101916
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19288,70,nan [nan-nan],
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18249,31,0.87 [0.28-2.67],0.8029455473457447
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19484,31,0.82 [0.26-2.60],0.7327542397557115
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",15686,31,0.88 [0.29-2.68],0.8159245149957106
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Alcohol dependence,18256,38,nan [nan-nan],
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,18213,45,1.20 [0.56-2.59],0.6360892016844066
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15684,29,1.51 [0.76-3.02],0.237884541497956
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",15858,203,1.09 [0.76-1.57],0.6366305925377977
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression,18356,180,1.02 [0.68-1.53],0.934218558775596
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression or dysthymia,15584,156,0.93 [0.59-1.49],0.7723991259615673
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",15745,90,1.43 [0.96-2.12],0.0791561300478431
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Other anxiety disorders,18371,53,1.00 [0.47-2.11],0.9993435242495986
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,16094,1229,1.16 [1.01-1.34],0.0350984015931084
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14142,84,1.42 [0.97-2.07],0.069111868923933
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19476,63,1.54 [1.05-2.27],0.0280567246677274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18476,381,1.30 [1.04-1.63],0.0201259463504093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,18204,109,0.59 [0.29-1.18],0.1342867957560655
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,18144,49,0.97 [0.44-2.12],0.930993833523503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19363,44,0.89 [0.37-2.16],0.7974953375787764
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18605,95,1.50 [1.05-2.14],0.0245247979075257
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,18222,127,1.72 [1.29-2.28],0.0001793316427682
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,19123,97,1.87 [1.40-2.51],2.331029247103349e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18552,582,1.18 [0.97-1.44],0.0916306969496994
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18054,84,1.27 [0.79-2.06],0.3233949639299853
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18324,354,1.11 [0.85-1.45],0.4555392447350633
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19245,64,0.89 [0.43-1.85],0.7474096474817281
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,19230,49,0.84 [0.35-2.03],0.7055469457435504
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,19094,95,0.55 [0.26-1.17],0.1217397725256819
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",18833,354,1.04 [0.79-1.38],0.7681536598522758
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18692,213,1.08 [0.76-1.53],0.6555595530032114
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18530,51,1.00 [0.47-2.11],0.9992534564094814
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18589,110,0.78 [0.43-1.42],0.4171523615701832
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18565,86,1.14 [0.68-1.91],0.6244526998613349
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,15011,212,1.14 [0.81-1.61],0.4484763794113755
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,15310,511,1.18 [0.95-1.47],0.13156300522055
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,18383,233,1.07 [0.76-1.49],0.707965831727176
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19196,52,1.54 [0.90-2.61],0.1141346923162089
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2165,52,1.42 [0.81-2.51],0.2195061957830159
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17083,52,1.57 [0.92-2.67],0.0987271260687389
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,18735,115,0.85 [0.49-1.48],0.5668158741072783
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,18681,61,0.67 [0.28-1.60],0.3724552807203122
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",18788,54,0.78 [0.32-1.85],0.5680578232565956
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,18990,81,0.72 [0.34-1.52],0.387846723655367
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19475,115,1.17 [0.76-1.80],0.4651209150879947
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,18574,98,1.39 [0.95-2.05],0.0898747412108078
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,12051,3714,1.19 [1.07-1.33],0.001831779357234
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,18775,80,1.29 [0.82-2.04],0.2666372861752764
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",12814,2576,1.19 [1.06-1.34],0.0029131581046008
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,12840,2602,1.21 [1.07-1.35],0.0015452516381443
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10302,64,1.84 [1.26-2.67],0.0014247621765061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17157,1465,1.15 [1.00-1.32],0.0446546239961341
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,16561,869,1.12 [0.93-1.34],0.2231444556010767
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18401,266,1.12 [0.82-1.54],0.4807763835433577
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18688,553,1.11 [0.89-1.38],0.3717052787157273
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19412,111,0.97 [0.57-1.65],0.9062170631946792
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16044,352,1.17 [0.90-1.52],0.2409182716409253
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,16842,1172,1.15 [0.99-1.34],0.0691577340278317
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18581,114,1.31 [0.88-1.95],0.181650449969117
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,18786,237,1.23 [0.92-1.66],0.1660714042024784
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18576,109,1.07 [0.66-1.74],0.7764553911873262
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18577,110,1.08 [0.66-1.74],0.7668995695861361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10343,105,1.16 [0.73-1.85],0.5348886472605172
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14494,59,1.11 [0.57-2.12],0.7638217778049021
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,14570,135,1.25 [0.84-1.85],0.2739846425680579
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7773,113,1.23 [0.78-1.93],0.3780281428177167
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,8217,557,1.29 [1.04-1.61],0.0227567935442766
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,14515,80,1.61 [1.13-2.31],0.0089922253085472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,14541,106,1.26 [0.82-1.94],0.2990782625209826
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18208,241,1.25 [0.93-1.70],0.1427876396793798
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",18519,159,0.94 [0.59-1.48],0.7740340834966798
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",18547,143,1.01 [0.64-1.59],0.974953504422231
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",18635,125,1.00 [0.61-1.64],0.9953727477849338
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18186,84,1.20 [0.73-1.98],0.4759006553655618
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18250,148,1.05 [0.68-1.63],0.8136357108455755
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18129,139,1.20 [0.80-1.79],0.3720355422441107
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18107,117,1.16 [0.74-1.82],0.5183025344670643
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19309,112,1.15 [0.72-1.82],0.5596832959464972
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,18417,427,1.08 [0.84-1.38],0.5488106464545235
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,18209,93,0.88 [0.48-1.63],0.6903865823070776
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,14482,1825,1.14 [1.00-1.29],0.04888891945099
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19421,71,0.64 [0.28-1.48],0.2974602703451076
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,17481,223,1.41 [1.08-1.85],0.0120008783294939
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",17456,198,1.44 [1.08-1.90],0.0114325016128796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,18521,243,1.05 [0.74-1.47],0.7951042737694743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,18515,237,0.97 [0.67-1.40],0.8669895366090727
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,18929,462,0.93 [0.72-1.22],0.6166769635355075
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,18542,75,0.94 [0.49-1.80],0.8508027061057315
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,18584,117,0.87 [0.50-1.51],0.6262924800793784
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18757,290,0.91 [0.65-1.28],0.5961087970497664
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,18582,115,0.66 [0.35-1.26],0.2072483455360119
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6274,64,1.58 [0.96-2.60],0.0720709453365189
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,16900,956,1.15 [0.98-1.36],0.0941528792281145
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,18172,207,1.19 [0.84-1.70],0.330068573018408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18214,249,1.21 [0.89-1.66],0.2232780371916274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18214,249,1.21 [0.89-1.66],0.2232780371916274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18096,720,1.07 [0.88-1.31],0.4765432269926083
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Asthma,12781,720,1.12 [0.92-1.37],0.2404398788608647
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",12462,720,1.14 [0.94-1.38],0.1960437187313837
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",12774,713,1.13 [0.93-1.37],0.2246395686532176
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19066,119,1.37 [0.94-1.98],0.0980999925630906
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,18154,93,1.61 [1.12-2.30],0.0091852959897004
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19142,93,1.58 [1.12-2.23],0.0099093622294198
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18148,87,1.60 [1.10-2.32],0.0136163649488962
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,17214,115,1.64 [1.23-2.19],0.0008496170406908
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,17343,244,1.43 [1.11-1.83],0.0049383263993574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18133,115,1.24 [0.81-1.90],0.3144233299507996
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,12640,5376,1.11 [1.01-1.22],0.0260241887339569
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19181,292,1.02 [0.75-1.39],0.8990871747410858
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19551,32,1.03 [0.41-2.56],0.9535367876088714
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,19552,30,1.17 [0.51-2.70],0.7158899629203874
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,18975,86,1.20 [0.73-1.96],0.4663934254529509
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18966,77,0.92 [0.48-1.76],0.8099892121655292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19547,35,0.95 [0.37-2.40],0.9107367470393856
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18972,83,0.39 [0.16-0.95],0.0375858572831434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18746,82,1.34 [0.87-2.07],0.1799882367470179
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19457,54,1.28 [0.73-2.24],0.3962697841843272
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,13882,279,1.24 [0.94-1.65],0.1263939028712196
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",15735,2132,1.17 [1.05-1.31],0.0061873381091891
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,13948,345,1.22 [0.95-1.57],0.1195132003480194
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,14309,706,1.17 [0.97-1.41],0.1019075318234803
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,13677,74,0.68 [0.31-1.50],0.3413629223996832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13837,234,1.12 [0.81-1.56],0.5000018134849913
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13673,70,0.52 [0.21-1.29],0.1604329704971613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,13764,161,1.38 [0.99-1.92],0.0571777424338872
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,13729,126,1.04 [0.65-1.69],0.8577657041370399
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19416,91,0.63 [0.30-1.34],0.2306439405261265
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,13720,117,1.07 [0.66-1.73],0.7828980611559277
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),14412,809,1.08 [0.89-1.30],0.4390710467087255
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,19437,77,0.61 [0.27-1.36],0.2263309837783251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,14000,397,1.27 [1.03-1.58],0.0287126179500016
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,13794,191,0.57 [0.33-0.97],0.0387090163362442
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19433,100,1.00 [0.57-1.74],0.9966282934766368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,19425,65,0.67 [0.29-1.56],0.3539007871767893
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,16523,1730,1.05 [0.92-1.20],0.4576414333556711
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,15469,676,0.83 [0.65-1.05],0.1255586015972646
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,14901,108,0.95 [0.53-1.72],0.8739014919084812
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,14881,88,1.36 [0.86-2.14],0.1903065420779121
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15732,939,1.16 [0.98-1.36],0.0815527457388241
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18659,646,1.12 [0.92-1.36],0.2623714729071625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,14394,1935,1.04 [0.91-1.18],0.5593739334919721
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19262,37,1.05 [0.48-2.32],0.8999915073027516
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19507,47,1.00 [0.47-2.11],0.9990072667753797
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,18060,47,1.01 [0.48-2.10],0.9808181659330608
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18047,34,1.33 [0.70-2.52],0.3819725069682744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19434,122,1.09 [0.69-1.71],0.7082153899557929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,18135,122,1.10 [0.70-1.72],0.6722324680213673
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18126,113,1.12 [0.71-1.76],0.6369296296007819
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18547,534,1.08 [0.87-1.35],0.4893818588915714
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18539,526,1.09 [0.87-1.36],0.4385424394113693
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12569,110,1.17 [0.76-1.81],0.4696198950337337
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal stricture,19054,110,1.19 [0.77-1.83],0.433466264810195
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12529,70,1.36 [0.85-2.16],0.1953222025658
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,13195,736,1.03 [0.85-1.25],0.7710534164206757
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12595,136,1.17 [0.79-1.73],0.4313245982484888
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,12723,264,1.21 [0.92-1.60],0.1685184743332007
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,17834,240,1.20 [0.89-1.61],0.2346734376566996
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19154,77,1.12 [0.65-1.94],0.683460632157465
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12547,88,1.03 [0.58-1.82],0.9306879781728964
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12502,43,1.35 [0.72-2.54],0.347346670656388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13263,804,1.04 [0.86-1.26],0.6626184329353084
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,12764,305,1.15 [0.87-1.52],0.3157121912667114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19142,65,1.14 [0.63-2.06],0.6589985380258647
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,18801,101,1.20 [0.74-1.94],0.4638925999061725
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,18755,55,1.34 [0.74-2.43],0.3354893843189801
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18300,593,1.23 [1.02-1.48],0.0339287317031414
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,18187,480,1.30 [1.07-1.59],0.0091692031841503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,17806,99,1.30 [0.86-1.96],0.2103487508398044
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17750,43,0.93 [0.39-2.21],0.8705207173804618
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,17767,60,1.27 [0.72-2.23],0.4141046625798227
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19397,60,1.25 [0.70-2.21],0.450688161619712
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18288,276,1.33 [1.04-1.71],0.0222458627843097
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18069,57,1.50 [0.97-2.32],0.0654592851199216
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,18061,49,,
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18058,46,1.58 [0.97-2.56],0.0657344245246947
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18191,179,1.20 [0.85-1.70],0.2988153732158278
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,18186,174,1.18 [0.83-1.69],0.3623072872705976
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,16484,1360,1.01 [0.87-1.17],0.9144849059008312
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19110,98,1.11 [0.67-1.84],0.6856037601368322
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19215,373,0.92 [0.69-1.24],0.5908080703925971
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,17847,521,0.86 [0.66-1.12],0.2681309692060298
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,18682,327,1.10 [0.83-1.47],0.5118648507842098
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18413,58,0.66 [0.26-1.66],0.3794272386131322
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18586,231,1.12 [0.80-1.57],0.5089575925587078
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19283,80,1.25 [0.76-2.06],0.3697673236058136
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19261,58,1.49 [0.91-2.43],0.1141841228874436
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19251,48,1.67 [1.05-2.65],0.0304094776761552
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19205,62,1.32 [0.80-2.20],0.2778828393031686
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19204,61,1.30 [0.77-2.19],0.3208383627602913
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18886,44,0.99 [0.43-2.26],0.9827993453530256
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19151,309,0.93 [0.67-1.28],0.6384034500889744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17425,99,0.50 [0.23-1.09],0.0804560358028363
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17407,81,0.60 [0.27-1.32],0.2010948954255423
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17383,57,0.28 [0.09-0.88],0.0297059457383655
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17524,198,0.87 [0.57-1.33],0.5287260684014937
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17511,185,0.90 [0.59-1.38],0.6251467028797579
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,12809,3702,1.17 [1.06-1.29],0.0025363218496755
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,14158,2304,1.16 [1.03-1.30],0.0107569573550241
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,17364,1104,1.09 [0.93-1.28],0.2843086375223493
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12000,146,1.54 [1.17-2.01],0.0018189305157336
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,12320,466,1.32 [1.08-1.62],0.0062831785584721
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19113,140,1.57 [1.20-2.07],0.0010324702376571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19118,128,1.61 [1.22-2.11],0.0006431706656398
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,13204,1350,1.16 [1.00-1.34],0.0431435801971592
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",15350,1350,1.12 [0.97-1.29],0.1234491330007293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,11935,81,1.50 [0.98-2.31],0.0613867692217146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",18932,78,1.49 [0.97-2.29],0.0674830155005072
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,12078,224,1.07 [0.75-1.53],0.6991194657489731
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,11949,95,1.65 [1.20-2.28],0.0022103299928394
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,12226,372,1.25 [1.00-1.58],0.0546121548826977
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19360,187,1.47 [1.13-1.91],0.0042196076397659
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,12453,599,1.11 [0.89-1.38],0.3555517734696878
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,12304,450,1.21 [0.96-1.52],0.0995275132327951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,12974,1120,1.09 [0.93-1.28],0.2758616340858605
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11937,83,0.96 [0.53-1.76],0.9041996677166462
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12098,244,1.31 [1.02-1.69],0.0332394074929554
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11917,63,0.79 [0.36-1.75],0.5587621995812743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11930,76,1.60 [1.13-2.25],0.0075707477750059
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12224,370,0.93 [0.69-1.26],0.6391647515112231
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12185,331,0.93 [0.68-1.28],0.6486814533101692
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,14749,233,1.31 [0.98-1.74],0.0703426712809795
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18930,100,1.08 [0.65-1.80],0.7603800447102205
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,18887,57,1.69 [1.12-2.55],0.0122841257045108
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16254,67,1.38 [0.87-2.20],0.16721216234747
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,16504,317,1.33 [1.05-1.68],0.0167005576510533
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,16977,790,1.26 [1.07-1.48],0.0059191726868951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,16393,206,1.37 [1.04-1.81],0.0236644840352734
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16283,96,1.19 [0.75-1.91],0.4585329248831966
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",16771,584,1.24 [1.02-1.49],0.0270049740888986
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16225,38,0.75 [0.26-2.17],0.601181887256599
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16363,176,1.14 [0.79-1.63],0.4877529406050199
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16258,71,1.03 [0.56-1.89],0.9221739017917756
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16257,70,1.26 [0.75-2.13],0.3840672983437068
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16293,106,1.24 [0.81-1.90],0.3310595983678951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16239,52,0.98 [0.45-2.13],0.9503844729482974
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16431,244,1.33 [1.02-1.73],0.0320963642788744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16545,285,0.92 [0.65-1.29],0.6211968498641698
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16327,67,1.02 [0.54-1.94],0.9415917203405468
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16367,107,0.99 [0.59-1.67],0.9843793481335849
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16330,70,0.48 [0.19-1.20],0.1144528540212984
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16296,36,1.24 [0.61-2.53],0.5524802751312141
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16404,144,1.24 [0.88-1.76],0.2236772939196823
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16396,136,1.19 [0.82-1.73],0.3591718198496195
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16511,251,0.96 [0.68-1.37],0.8412761214236044
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16311,51,0.60 [0.22-1.64],0.3170021252079382
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16344,84,1.05 [0.59-1.86],0.8720598369565838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16377,117,1.15 [0.74-1.78],0.5344773658482473
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16304,44,0.86 [0.35-2.11],0.739846955049265
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",16643,383,1.18 [0.92-1.51],0.1859278686114741
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16419,159,1.16 [0.80-1.70],0.4352791357178518
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16473,213,1.18 [0.85-1.64],0.327962149076245
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,17559,199,1.17 [0.85-1.62],0.343329583303809
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,17715,355,1.14 [0.89-1.46],0.3138608825071715
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17390,30,1.60 [0.92-2.77],0.0942369713979561
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17396,36,0.84 [0.31-2.28],0.7392354351247993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17426,66,0.71 [0.32-1.58],0.4001360349180057
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,14373,3393,1.18 [1.07-1.30],0.0007337897789972
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,7500,709,1.21 [1.00-1.47],0.0494075164917035
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,16628,207,1.56 [1.21-2.00],0.0005502343659975
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16484,63,1.04 [0.54-2.00],0.9015982308679892
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,16712,44,1.95 [1.29-2.95],0.0016164996364842
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,16720,52,1.85 [1.28-2.68],0.0010609204858582
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16726,58,1.78 [1.20-2.64],0.0039521072237324
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19236,198,1.09 [0.76-1.56],0.64598535370127
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19077,64,1.76 [1.24-2.51],0.0017219383113412
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19186,148,1.03 [0.66-1.59],0.8994334332404929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19095,57,0.99 [0.48-2.07],0.9869254074535146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,17178,996,1.09 [0.92-1.28],0.3249846370629893
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,16268,86,1.05 [0.60-1.84],0.8637268177461566
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16256,74,1.08 [0.60-1.95],0.7992378797494366
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16478,296,1.02 [0.74-1.38],0.9226792853335368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16292,110,1.08 [0.67-1.77],0.7453177562707597
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,16805,623,1.16 [0.96-1.41],0.1278260081214983
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,7203,412,1.12 [0.87-1.45],0.3813877792904633
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6846,55,0.91 [0.41-1.99],0.8076957100279087
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,6845,54,2.17 [1.48-3.18],7.723702351061941e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6852,61,1.15 [0.59-2.21],0.6835152924428276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6866,75,1.50 [0.96-2.36],0.0760072654004763
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6880,89,1.27 [0.78-2.05],0.3394014470084796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10187,200,0.95 [0.64-1.40],0.7896422472613154
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10052,65,1.13 [0.64-1.98],0.6717079716600929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,10055,68,0.65 [0.28-1.50],0.3084345467915972
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10044,57,1.12 [0.60-2.09],0.7313833644739832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10164,142,0.78 [0.46-1.33],0.3664158688050041
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,10065,43,0.76 [0.30-1.97],0.5790712197267935
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10066,44,0.88 [0.37-2.12],0.7745626478635061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,9427,1554,1.15 [1.01-1.32],0.0311545316241588
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,7923,50,0.64 [0.24-1.75],0.3840401682122542
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7912,39,0.61 [0.19-1.95],0.409521300841089
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8286,413,1.20 [0.96-1.50],0.1150901986230983
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7954,81,0.86 [0.45-1.65],0.6556939149899943
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8276,403,1.15 [0.91-1.46],0.2276343713174049
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7997,124,1.03 [0.65-1.65],0.8933265427812274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8062,189,1.05 [0.72-1.53],0.8174696243846229
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,7886,13,0.93 [0.21-4.05],0.9202305735879518
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,7912,39,1.29 [0.69-2.40],0.4303271845602481
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",10287,54,1.41 [0.89-2.24],0.1472711848860176
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,10289,49,1.36 [0.82-2.26],0.228861889170898
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,10294,23,1.21 [0.49-2.98],0.672336891078233
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",10292,27,1.39 [0.68-2.83],0.3720683183747205
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7937,64,1.33 [0.82-2.16],0.2504044617956237
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7922,49,1.18 [0.62-2.24],0.6134331153648905
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7934,61,0.82 [0.37-1.82],0.6299889162994772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Irregular menses,10293,81,1.58 [1.14-2.17],0.0055973554630405
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",8046,173,1.55 [1.21-1.98],0.0004579409557241
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Menorrhagia,7951,78,1.65 [1.20-2.27],0.0021583771821988
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",10295,36,1.89 [1.31-2.72],0.0006197031767183
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7968,95,1.23 [0.82-1.84],0.3201583287485505
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7916,43,1.54 [0.97-2.44],0.0644377933486912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8427,554,1.10 [0.89-1.37],0.3735617417392843
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19110,68,0.79 [0.36-1.73],0.5558615168273828
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,16752,560,1.08 [0.87-1.34],0.4863758435858483
